(1 - 7 von 7
)
Biofrontera AG: CE Marking Granted for IndoorLux Collaborationwww.investegate.co.uk › rns › ce-marking-granted-f...
www.investegate.co.uk
· ... allows better medical care, at the same time minimising discomfort and morbidity," says Dr. Wilfried Priel, chairman of SwissRed AG.
PTA-News: Biofrontera AG: Neue ganzjährige Behandlungsmöglichkeit für...
www.finanznachrichten.de
· SwissRed AG: Dr. Wilfried Priel +41 (0) Brainwell Asset Solutions Jürgen Benker +49 (0) Ansprechpartner für Journalisten Cortent Kommunikation AG
Biofrontera : New year-round treatment option for daylight-PDT ...Market Screener
www.marketscreener.com
"Our controlled PDT technology allows better medical care, at the same time minimising discomfort and morbidity," says Dr. Wilfried Priel, chairman of ...
Biofrontera AG: New year-round treatment option for daylight-PDT for...
www.wallstreet-online.de
The IndoorLux® system simulates daylight-PDT under controlled conditions in dermatological practices and has now received European CE...
finanzen.net - Seite nicht gefunden
www.finanzen.net
PTA-News: Biofrontera AG: Neue ganzjhrige Behandlungsmglichkeit fr die daylight-PDT in dermatologischen Praxen | Nachricht | finanzen.net
PTA-News: Biofrontera AG: Neue ganzjährige ...OnVista
www.onvista.de
— Wilfried Priel, Verwaltungsrat der SwissRed AG. Prof. Hermann Luebbert, CEO der Biofrontera AG kommentiert: "IndoorLux® bietet Dermatologen eine ...
sortiert nach Relevanz / Datum